• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALLERGAN (COSTA RICA) STYLE 168 SALINE FILLED BREAST IMPLANT; PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALLERGAN (COSTA RICA) STYLE 168 SALINE FILLED BREAST IMPLANT; PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE Back to Search Results
Model Number 168-450
Medical Device Problem Code Fluid/Blood Leak (1250)
Health Effect - Clinical Codes Failure of Implant (1924); No Code Available (3191)
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Additional information regarding the event, product, or patient details has been requested of the reporter by allergan; no additional information is available at this time.A review of the device history record has been completed.No deviations or non-conformances noted.Device labeling: potential adverse events that may occur with saline-filled breast implant surgery include: reoperation, pain, wrinkling, asymmetry, implant palpability/visibility, implant removal, capsular contracture, changes in nipple and breast sensation, implant displacement/migration, implant deflation, scarring, infection, hematoma or seroma, breastfeeding complications, implant extrusion, necrosis, delayed wound healing, breast tissue atrophy/chest wall deformity, calcium deposits, and lymphadenopathy.Deflation ¿ breast implants are not lifetime devices.Saline breast implants deflate when the shell develops a tear or hole.Deflation can occur at any time after implantation, but they are more likely to occur the longer the implant is implanted.The following things may cause implants to deflate: damage by surgical instruments; folding or wrinkling of the implant shell; excessive force to the chest (e.G., during closed capsulotomy, which is contraindicated); trauma; compression during mammographic imaging; and severe capsular contracture.Breast implants may also simply wear out over time.Laboratory studies have identified some of the causes of deflation for allergan¿s product; however, it is not conclusively known whether these tests have identified all causes of deflation.Unsatisfactory results ¿ patients should be informed that dissatisfaction with cosmetic results related to such things as scar deformity, hypertrophic scarring, capsular contracture, asymmetry, wrinkling, implant displacement/migration, incorrect size, and implant palpability/visibility may occur.Careful surgical planning and technique can minimize, but not preclude, the risk of such results.Pre-existing asymmetry may not be entirely correctable.Revision surgery may be indicated to maintain patient satisfaction but carries additional considerations and risks.
 
Event or Problem Description
Physician reported right side deflation and that the side is "grossly deformed." device has been explanted.
 
Additional Manufacturer Narrative
Device evaluation: visual analysis of the returned device identified: black particles on 20% of shell, mold like appearance, fluids inside device and one opening curved in posterior side.A leak test was performed which identify one opening on the device.Microscopic analysis was performed which identified: one opening curved in posterior side displayed striated edge consistent with the use of a surgical tool.A fill inspection was performed and identified no blockage in valve.Based on the device analysis the final assessment is: one opening due to surgical damage.
 
Event or Problem Description
Physician reported right side deflation and that the side is "grossly deformed." device has been explanted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STYLE 168 SALINE FILLED BREAST IMPLANT
Common Device Name
PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE
Manufacturer (Section D)
ALLERGAN (COSTA RICA)
900 parkway global park
zona franca
CS 
MDR Report Key6795831
Report Number9617229-2017-00864
Device Sequence Number13485375
Product Code FWM
UDI-Device Identifier10888628000865
UDI-Public(01)10888628000865(10)2700435(11)150130(17)181230
Combination Product (Y/N)N
Initial Reporter StateKY
Initial Reporter CountryUS
PMA/510(K) Number
P990074
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2017
Device Explanted Year2017
Reporter Type Manufacturer
Report Source consumer,health professional
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 09/18/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date12/30/2018
Device Model Number168-450
Device Catalogue Number168-450
Device Lot Number2700435
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/18/2017
Initial Date Received by Manufacturer 07/18/2017
Supplement Date Received by Manufacturer08/28/2017
Initial Report FDA Received Date08/15/2017
Supplement Report FDA Received Date09/18/2017
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
-
-